Molecular Imaging and Radionuclide Therapy

Interesting Images

False Positive Perfusion/Ventilation SPECT Study for Pulmonary Embolism in a Patient with Fontan Circulation

10.4274/mirt.70883

Emmanouil Panagiotidis

Received Date: 19.12.2016 Accepted Date: 24.07.2017 Mol Imaging Radionucl Ther 2017;26(3):131-134 PMID: 28976338

Tc-99m-methylene diphosphonate (MDP) whole body scintigraphy is the method of choice for detection of metastatic bone diseases. It is primarily used to help diagnose various bone-related conditions such as primary or metastatic cancer of the bone, location of bone inflammation, and fractures that may not be visible on traditional X-ray images, as well as detection of bone damage due to infections and other conditions. In addition, bone scanning is often used for the follow-up or evaluation of response to treatment in some malignancies like prostate and breast cancers. Pathologies of other systems can also be incidentally detected on whole body bone scan. Herein we present an interesting image of an active thyroid nodule that showed Tc-99m MDP uptake in a prostate cancer patient.

Keywords: Fontan circulation, perfusion/ventilation, single-photon emission computed tomography, pulmonary embolism, computed tomography pulmonary angiogram

Ethics

Informed Consent: Consent form was filled out by all participants.

Peer-review: Externally and internally peer-reviewed.

Authorship Contributions

Surgical and Medical Practices: D.Ç., Concept: D.Ç., Design: D.Ç., Data Collection or Processing: Ş.A., M.K., E.Ç., Analysis or Interpretation: D.Ç., M.A., Literature Search: D.Ç., M.A., Writing: D.Ç.

Conflict of Interest: The authors declared that they have no conflict of interests.

Financial Disclosure: The authors declared that this study received no financial support.

1.   Langsteger W, Rezaee A, Pirich C, Beheshti M. 18F-NaF-PET/CT and 99mTc MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer. Semin Nucl Med 2016;46:491-501.
2.   Subramanian G, McAfee JG. A new complex for 99mTc for skeletal imaging. Radiology 1971;99:192-196.
3.   Subramanian G, McAfee JG, Blair RJ, Kallfelz FA, Thomas FD. Technetium-99m methylene diphosphonate: a superior agent for skeletal imaging: comparison with other technetium cornplexes. J Nucl Med 1975;16:744-755.
4.   Peller PJ, Ho VB, Kransdorf MJ. Extraosseous Tc-99m MDP uptake: a pathophy-siologic approach. Radiographics 1993;13:715-734.
5.   Bares R. Skeletal scintigraphy in breast cancer management. QJ Nucl Med 1998;42:43-48.
6.   Padhy AK, Gopinath PG, Amini AC. Myocardial, pulmonary, diaphragmatic, gastric, splenic, and renal uptake ofTc-99m MDP inpatients with persistent, severe hypercalcemia. Clin NucI Med 1990;15:648-664.